Ovarian Cancer Clinical Trial
With Love, Grandma (“Con Cariño, Abuelita”) Pilot Study
Summary
The purpose of this study is to assess the feasibility, acceptability, and preliminary effects of a digital (web and mobile-phone-based) program to improve lifestyle behaviors (physical activity, dietary intake) among Hispanic female cancer survivors and adult daughters.
Eligibility Criteria
Cancer Survivor Inclusion Criteria:
Grandmother
Self-identifies as Hispanic
Diagnosis of breast cancer (stages I-III), endometrial or ovarian cancer (stages I-II)
Completed active treatment (i.e., surgery, chemotherapy, and/or radiation)
Body Mass Index (BMI) ≥ 25 (overweight range)
Engages in <150 minutes/week of moderate physical activity
English or Spanish speaking
Owns a mobile device with internet access (e.g., smartphone, tablet)
Lives in South Florida
Daughter of Cancer Survivor Inclusion Criteria:
Adult daughter of the identified cancer survivor (21 years of age or older)
Has at least 1 living child ages ≤16 years old
Body Mass Index (BMI) ≥ 25 (overweight range) OR engages in <150 minutes/week of moderate physical activity
English or Spanish speaking
Owns a mobile device with internet access (e.g., smartphone, tablet)
Lives in South Florida
Daughter of Cancer Survivor Exclusion Criteria:
Has been diagnosed with distant metastatic cancer
Has not completed active treatment (i.e., surgery, chemotherapy, and/or radiation)
Has uncontrolled schizophrenia or bipolar disorder
Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions,wheelchair bound).
Cancer Survivor Exclusion Criteria:
Has uncontrolled schizophrenia or bipolar disorder
Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions, wheelchair bound)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Miami Florida, 33136, United States More Info
Principal Investigator
How clear is this clinincal trial information?